Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial and Functional Immune Profiling Identifies Impaired Vascular Repair in Human Myocardial Infarction.

Biomedicines·2026
Same author

PEO-Reinforced Hydrogel-Forming PVA Nanofibrous Mats Prepared by Coaxial Electrospinning: A Physicochemical Basis for Biomedical Evaluation.

Chemical & pharmaceutical bulletin·2026
Same author

PRKAG2 Cardiomyopathy: A Case-Control Study on the Diagnostic Yield Of Histopathology and Ultrastructural Analysis from Endomyocardial Biopsy.

Arquivos brasileiros de cardiologia·2026
Same author

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Circulation·2025
Same author

Tranexamic acid inhibits group A streptococci-mediated fibrinolysis <i>in vitro</i> and modulates host immune cells <i>in vivo</i>.

Frontiers in immunology·2025
Same author

Cardiotoxicity of Metal Implant Wear: Emerging Insights into the Roles of Cobalt and Chromium.

Tissue engineering. Part B, Reviews·2025
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.9K

(Re-)programming of subtype specific cardiomyocytes.

Frauke Hausburg1, Julia Jeannine Jung1, Matti Hoch2

  • 1Reference and Translation Center for Cardiac Stem Cell Therapy (RTC), Department of Cardiac Surgery, Rostock University Medical Center, Schillingallee 69, 18057 Rostock, Germany; Department Life, Light and Matter of the Interdisciplinary Faculty at Rostock University, Albert-Einstein-Straße 25, 18059 Rostock, Germany.

Advanced Drug Delivery Reviews
|September 17, 2017
PubMed
Summary
This summary is machine-generated.

Cardiovascular regenerative medicine faces challenges due to limited cardiomyocyte regeneration. Stem cell and direct cell reprogramming offer promising therapeutic strategies for cardiac repair and developing biological pacemakers.

Keywords:
Cardiovascular developmentESCNodal cellsPacemakerSubtype differentiationSystem-based data analysisiPSC

More Related Videos

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K

Related Experiment Videos

Last Updated: Feb 22, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.9K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

7.8K
Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5
10:05

Improved Generation of Induced Cardiomyocytes Using a Polycistronic Construct Expressing Optimal Ratio of Gata4, Mef2c and Tbx5

Published on: November 13, 2015

9.2K

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Stem Cell Science

Background:

  • Adult cardiomyocytes (CMs) have limited regenerative capacity, hindering treatments for heart disease.
  • Chronic degenerative cardiac disorders result in cellular loss and dysfunction, leading to high mortality.
  • Stem cell-based therapies and direct cell reprogramming are emerging as potential curative approaches.

Purpose of the Study:

  • To review advancements in cardiovascular stem cell and reprogramming research.
  • To explore the generation of specific cardiac cell subtypes, including pacemaker cells.
  • To discuss applications in biological pacemakers and in vitro drug testing.

Main Methods:

  • Review of induced pluripotent stem cells (iPSCs) as a source for cardiomyocyte production.
  • Discussion of direct somatic cell reprogramming into cardiomyocytes.
  • Focus on generating pure, specific cardiac cellular subtypes.

Main Results:

  • Induced pluripotent stem cells (iPSCs) provide an alternative to embryonic stem cells (ESCs) for autologous cardiomyocyte generation.
  • Direct reprogramming of somatic cells into cardiomyocytes is a significant development.
  • The generation of specific cardiac cell subtypes is crucial for clinical applications.

Conclusions:

  • Stem cell programming and direct cell reprogramming hold significant promise for treating heart disease.
  • The development of biological pacemakers and improved in vitro drug testing models are key applications.
  • Generating pure cardiac cell subtypes is essential for advancing cardiovascular regenerative medicine.